Incidence and Risk Factors of Acute Otitis media and Otitis media with Effusion in Children of Different Age Groups

2015 ◽  
pp. 47-56 ◽  
Author(s):  
G. Pestalozza ◽  
M. Romagnoli ◽  
E. Tessitore
Keyword(s):  
Risk Factors ◽  
Otitis Media ◽  
Otitis Media With Effusion ◽  
Age Groups ◽  
Acute Otitis Media

scholarly journals The validity of topical drug therapy for otitis media with effusion

2021 ◽  
pp. 80-84
Author(s):  
S. V. Morozova ◽  
K. V. Eremeeva ◽  
W. H.A. Suaifan
Keyword(s):  
Tympanic Membrane ◽  
Otitis Media ◽  
Otitis Media With Effusion ◽  
Age Groups ◽  
Acute Otitis Media ◽  
Combination Drug ◽  
Initial Stage ◽  
Topical Analgesics ◽  
Anti Inflammatory ◽  
Inflammatory Effect

Otitis media with effusion is difficult to diagnose, since the course of the disease is mostly asymptomatic, while the initial stage of the disease is very similar to Eustachiitis or the pre-perforative stage of acute otitis media. At this stage, dysfunction of the auditory tube and negative pressure in the tympanic cavity creates the conditions for the production of transudate, which clinically, in addition to hearing loss, is accompanied by soreness, a feeling of congestion, pressure, fluid transfusion in the ear. When conducting local medical procedures, they are primarily guided by the condition of the mucous membrane of the eustachian tube, nasopharynx and nasal cavity, but changes in the eardrum are no less important. Thus, the use of topical analgesics with an anti-inflammatory effect becomes no less relevant in the treatment.A literature review was carried out with an analysis of scientific research data on the use of a topical combination drug that has a local anesthetic and anti-inflammatory effect in the treatment of diseases of the external and middle ear.Analysis of the literature showed that the use of lidocaine-phenazone-containing drops promotes rapid regression of the inflammation in the external auditory canal and the tympanic membrane, as well as relieving of pain. It can be used both in children (including newborns) and in adults who are suffering from otitis media but with intact tympanic membrane, including otitis media with effusion.Combined topical drugs containing lidocaine-phenazone demonstrate efficacy and safety in the treatment of catarrhal and otitis media with effusion in all age groups.

scholarly journals Risk factors for the formation of effusion in tympanic cavity and its clinical features in adults

2021 ◽  
Vol 6 (2) ◽  
pp. 25-29
Author(s):  
Sviatlana M. Kalesnikava ◽  
Elena P. Merkulava ◽  
Katsiaryna S. Yadchanka
Keyword(s):  
Risk Factors ◽  
Otitis Media ◽  
Paranasal Sinuses ◽  
Otitis Media With Effusion ◽  
Inflammatory Diseases ◽  
Acute Otitis Media ◽  
Tympanic Cavity ◽  
Chronic Form ◽  
Clinical Hospital ◽  
Predominantly Female

Objectives to analyse the risk factors for developing effusion in the tympanic cavity in adults. Material and methods. We examined patients who were treated for otitis media with effusion (n=51) aged 18-70 years in the ENT department of the 11 Minsk City Clinical Hospital and the Gomel Regional Clinical Hospital during the 2018-2020 years. Results. The acute otitis media with effusion was significantly prevailing in patients of the age group 31-40 years, the chronic form predominated in people of 51-60 years old, and in all analyzed groups women dominated. In 81% of chronic inflammation of the paranasal sinuses the chronic form of otitis media with effusion prevails. Conclusion. The most frequent risk factors for the formation of the tympanic exudate were inflammatory diseases of the paranasal sinuses, pathology of the nasal cavity, predominantly female sex of working age. According to the research, it was reliably proved that smoking and rural or urban residence were not a risk factor for the formation of tympanic effusion.

scholarly journals Tragal perichondrium as graft material in tympanoplasty: our experience

2021 ◽  
Vol 7 (3) ◽  
pp. 430
Author(s):  
Vivek K. Pathak ◽  
Pradeepti Nayak ◽  
Sonali Tyagi ◽  
Rohit Chaudhary
Keyword(s):  
Otitis Media ◽  
Middle Ear ◽  
Otitis Media With Effusion ◽  
Age Groups ◽  
Acute Otitis Media ◽  
Chronic Otitis Media ◽  
Uttar Pradesh ◽  
Cell System ◽  
P Value ◽  
Graft Material

<p class="abstract"><strong>Background:</strong> It has been defined as a permanent abnormality of pars tensa or flaccida, as a result of acute otitis media, negative middle ear pressure or otitis media with effusion. It manifests clinically as ear discharge and decreased hearing and may lead to numerous changes in the tympanic membrane, middle ear cleft, and mastoid air cell system. It has been classified into two types: mucosal and squamosal types. Chronic otitis media (COM) is a very common condition in developing countries in both adult and paediatric age groups. This study has been conducted to determine the outcome and graft uptake of tragal perichondrium in type 1 tympanoplasty.</p><p class="abstract"><strong>Methods:</strong> The prospective analytical study was conducted department of otorhinolaryngology, School of Medical Sciences and Research, Greater Noida, Uttar Pradesh, India over a period of 12months from 01 January 2019 to 31 December 2019. 30 patients according to inclusion criterion underwent tympanolpasty using tragal perichondrium were included in study. The data obtained was analyzed using statistical package for the social sciences (SPSS), version 21.0. P value less than 0.05 was taken as statically significant.  </p><p class="abstract"><strong>Results:</strong> Preoperative mean hearing loss was 38.45±7.01 dB, mean air bone gap was 20.20±3.75 dB, and postoperative air bone gap was reduced to an average of 10.86±3.82 dB. 8.51 dB of hearing gain was achieved and an air bone gap réduction of 8.51 dB was observed.</p><p class="abstract"><strong>Conclusions:</strong> Our study concluded tragal perichondrium is a suitable graft material is n mucosal type of COM.</p>

scholarly journals Association of Receipt of Antibiotics with Patient Satisfaction for Caregivers of Children Presenting to Urgent-Care Settings

2020 ◽  
Vol 41 (S1) ◽  
pp. s134-s135
Author(s):  
Diane Liu ◽  
NORA FINO ◽  
Benjamin Haaland ◽  
Adam Hersh ◽  
Emily Thorell ◽  
...  
Keyword(s):  
Patient Satisfaction ◽  
Otitis Media ◽  
Respiratory Infections ◽  
Otitis Media With Effusion ◽  
Multivariable Analysis ◽  
Acute Otitis Media ◽  
Skewed Distribution ◽  
Urgent Care ◽  
Provider Type ◽  
Patient Dissatisfaction

Background: The Press Ganey (PG) Medical Practice Survey is a commonly used questionnaire for measuring patient experience in healthcare. Our objective was to evaluate the PG surveys completed by caregivers of children presenting for urgent care evaluation of acute respiratory infections (ARIs) to determine any correlation with receipt of antibiotics during their visit. Methods: We evaluated responses to the PG urgent-care surveys for encounters of children <18 years presenting with ARIs (ie, sinusitis, bronchitis, pharyngitis, upper respiratory infection, acute otitis media, or serous otitis media with effusion) within 9 University of Utah urgent-care centers. Scores could range from 0 to 100. Because the distributions of scores followed right- skewed distribution with a high ceiling effect, we defined scores as dissatisfied with their care (≤25th percentile) and satisfied with their care (scores >25th percentile). Univariate and multivariable generalized mixed-effects logistic regression was used to assess correlates of patient dissatisfaction. Random intercepts were included for each provider to account for correlation within the same provider. Separate models were used for each PG component score. Multivariable models adjusted for receipt of antibiotics, age, gender, race, ethnicity, and provider type. Results: Overall, 388 of 520 responses (74.6%) indicated satisfaction and 132 responses (25.4%) indicated dissatisfaction. Among patients who did not receive antibiotics, 87 of 284 responses (30.6%) indicated dissatisfaction versus 45 of 236 (19.1%) who did receive antibiotics. Among patients who were dissatisfied with their clinician, raw clinician PG scores were higher among patients who received antibiotics (mean, 64.5; standard deviation [SD], 16.9) versus those who did not receive antibiotics (mean, 54.7; SD, 24.4; P = .015) (Table 1). In a multivariable analysis, receipt of antibiotics was associated with a reduction in patient dissatisfaction overall (odds ratio, 0.55; 95% CI, 0.36–0.85). Conclusions: Overall, most responses for patients seen for ARIs in pediatric urgent care were satisfied. However, a significantly higher proportion of responses for patients who did not receive antibiotics were dissatisfied than for those patients who received antibiotics. Antibiotic stewardship strategies to communicate appropriate prescribing while preserving patient satisfaction are needed in pediatric urgent-care settings.Funding: NoneDisclosures: None

scholarly journals Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Amanda Jane Leach ◽  
Edward Kim Mulholland ◽  
Mathuram Santosham ◽  
Paul John Torzillo ◽  
Peter McIntyre ◽  
...  
Keyword(s):  
Haemophilus Influenzae ◽  
Otitis Media ◽  
Conjugate Vaccine ◽  
Otitis Media With Effusion ◽  
Controlled Trial ◽  
Acute Otitis Media ◽  
Trial Registration ◽  
Open Label ◽  
Suppurative Otitis Media ◽  
Link Type

Abstract Background Aboriginal children living in Australian remote communities are at high risk of early and persistent otitis media, hearing loss, and social disadvantage. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are the primary pathogens. We compared otitis media outcomes in infants randomised to either a combination of Synflorix™ (PHiD-CV10, with protein D of NTHi) and Prevenar13™ (PCV13, with 3, 6A, and 19A), with recommended schedules for each vaccine alone. We previously reported superior broader overall immunogenicity of the combination schedule at 7 months, and early superiority of PHiD-CV10 compared to PCV13 at 4 months. Methods In an open-label superiority trial, we randomised (1:1:1) Aboriginal infants at 28 to 38 days of age, to either Prevenar13™ (P) at 2–4-6 months (_PPP), Synflorix™ (S) at 2–4-6 months (_SSS), or Synflorix™ at 1–2-4 months plus Prevenar13™ at 6 months (SSSP). Ears were assessed using tympanometry at 1 and 2 months, combined with otoscopy at 4, 6, and 7 months. A worst ear diagnosis was made for each child visit according to a severity hierarchy of normal, otitis media with effusion (OME), acute otitis media without perforation (AOMwoP), AOM with perforation (AOMwiP), and chronic suppurative otitis media (CSOM). Results Between September 2011 and September 2017, 425 infants were allocated to _PPP(143), _SSS(141) or SSSP(141). Ear assessments were successful in 96% scheduled visits. At 7 months prevalence of any OM was 91, 86, and 90% in the _PPP, _SSS, and SSSP groups, respectively. There were no significant differences in prevalence of any form of otitis media between vaccine groups at any age. Combined group prevalence of any OM was 43, 57, 82, 87, and 89% at 1, 2, 4, 6, and 7 months of age, respectively. Of 388 infants with ear assessments at 4, 6 and 7 months, 277 (71.4%) had OM that met criteria for specialist referral; rAOM, pOME, or CSOM. Conclusions Despite superior broader overall immunogenicity of the combination schedule at 7 months, and early superiority of PHiD-CV10 compared to PCV13 at 4 months, there were no significant differences in prevalence of otitis media nor healthy ears throughout the first months of life. Trial registration ACTRN12610000544077 registered 06/07/2010 and ClinicalTrials.govNCT01174849 registered 04/08/2010.

Sign in / Sign up

Export Citation Format

Share Document